Detection of Trypanosoma cruzi antibodies in multitransfused patients in Colombia
Related Experiment Video
Updated: Feb 21, 2026
Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
Published on: January 27, 2019
Mauricio Beltrán1, Andrea Herrera, Astrid Carolina Flórez
1Coordinación Nacional de Red de Bancos de Sangre, Instituto Nacional de Salud, Bogotá, D.C., Colombia Red Chagas Colombia, Bogotá, D.C., Colombia. mbeltrand@ins.gov.co.
Introduction:
Chagas disease is a public health problem in Latin America. Even though vector-borne infection is the most important transmission mode for this disease, other modes such as transfusions require evaluation.
Objective:
To describe the prevalence of T. cruzi infection in multitransfused patients.
Materials And Methods:
We detected IgG antibodies against T. cruzi by two immunoassays in samples from multitransfused patients in four hospitals located in Bogotá and Medellín, Colombia. We analyzed the association with known risk factors, and we calculated the odds ratios (OR) with 95% confidence intervals using Stata 11™ statistical software.
Results:
In total, 479 samples were tested. Overall, T. cruzi antibody prevalence was 1.88% (nine patients). Five were onco-hematological patients, two were hemodialyzed, one had thalassemia, and one had suffered acute blood loss. We found no hemophilia patients. There was no association between known risk factors for transfusion-transmitted infection (such as the number of transfusion events, number of blood units and type of blood component) and the presence of anti-T. cruzi antibodies in this study. Only the hepatitis C virus infection showed a positive association with the presence of anti-T. cruzi antibodies (OR=5.68, 95% CI: 1.36-23.63).
Conclusions:
The results of this study showed a low frequency of T. cruzi infection in multitransfused patients, suggesting that the risk of transfusion infection in Colombia is low. Known risk factors for transfusion-related infection were not associated with the presence of anti-T. cruzi antibodies.
